HEADER IMMUNE SYSTEM/RNA 02-DEC-18 6IV6 TITLE CRYO-EM STRUCTURE OF ACRVA5-ACETYLATED MBCAS12A IN COMPLEX WITH CRRNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: RNA (59-MER); COMPND 7 CHAIN: G; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MORAXELLA BOVOCULI; SOURCE 3 ORGANISM_TAXID: 386891; SOURCE 4 GENE: AAX07_00205; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS ENZYME, IMMUNE SYSTEM, IMMUNE SYSTEM-RNA COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR L.DONG,N.LI,X.GUAN,Y.ZHU,N.GAO,Z.HUANG REVDAT 3 06-NOV-19 6IV6 1 CRYST1 SCALE REVDAT 2 17-APR-19 6IV6 1 JRNL REVDAT 1 10-APR-19 6IV6 0 JRNL AUTH L.DONG,X.GUAN,N.LI,F.ZHANG,Y.ZHU,K.REN,L.YU,F.ZHOU,Z.HAN, JRNL AUTH 2 N.GAO,Z.HUANG JRNL TITL AN ANTI-CRISPR PROTEIN DISABLES TYPE V CAS12A BY JRNL TITL 2 ACETYLATION. JRNL REF NAT. STRUCT. MOL. BIOL. V. 26 308 2019 JRNL REFN ESSN 1545-9985 JRNL PMID 30936526 JRNL DOI 10.1038/S41594-019-0206-1 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 93000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6IV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1300009957. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CPF1-CRRNA REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 81.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 260 REMARK 465 GLY A 261 REMARK 465 GLU A 262 REMARK 465 ALA A 263 REMARK 465 GLY A 264 REMARK 465 SER A 265 REMARK 465 ARG A 266 REMARK 465 LYS A 267 REMARK 465 ILE A 268 REMARK 465 CYS A 283 REMARK 465 HIS A 284 REMARK 465 LYS A 285 REMARK 465 LEU A 300 REMARK 465 SER A 301 REMARK 465 ASP A 302 REMARK 465 GLY A 303 REMARK 465 MET A 304 REMARK 465 GLY A 305 REMARK 465 VAL A 306 REMARK 465 SER A 307 REMARK 465 PHE A 308 REMARK 465 LEU A 309 REMARK 465 PRO A 310 REMARK 465 GLU A 391 REMARK 465 ARG A 392 REMARK 465 PHE A 393 REMARK 465 ALA A 394 REMARK 465 LYS A 395 REMARK 465 ALA A 396 REMARK 465 LYS A 397 REMARK 465 THR A 398 REMARK 465 ASP A 399 REMARK 465 ASN A 400 REMARK 465 ALA A 401 REMARK 465 LYS A 402 REMARK 465 ALA A 403 REMARK 465 LYS A 404 REMARK 465 LEU A 405 REMARK 465 THR A 406 REMARK 465 LYS A 407 REMARK 465 GLU A 408 REMARK 465 LYS A 409 REMARK 465 ASP A 410 REMARK 465 LYS A 411 REMARK 465 PHE A 412 REMARK 465 ILE A 413 REMARK 465 LYS A 414 REMARK 465 GLY A 415 REMARK 465 VAL A 416 REMARK 465 HIS A 417 REMARK 465 SER A 418 REMARK 465 LEU A 419 REMARK 465 G G -13 REMARK 465 U G -12 REMARK 465 C G -11 REMARK 465 U G -10 REMARK 465 A G -9 REMARK 465 A G -8 REMARK 465 C G -7 REMARK 465 G G -6 REMARK 465 A G -5 REMARK 465 C G -4 REMARK 465 C G -3 REMARK 465 U G -2 REMARK 465 U G -1 REMARK 465 U G 0 REMARK 465 U G 1 REMARK 465 A G 2 REMARK 465 G G 29 REMARK 465 U G 30 REMARK 465 C G 31 REMARK 465 C G 32 REMARK 465 A G 33 REMARK 465 U G 34 REMARK 465 G G 35 REMARK 465 U G 36 REMARK 465 C G 37 REMARK 465 U G 38 REMARK 465 G G 39 REMARK 465 U G 40 REMARK 465 U G 41 REMARK 465 A G 42 REMARK 465 C G 43 REMARK 465 U G 44 REMARK 465 C G 45 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 LYS A 88 CG CD CE NZ REMARK 470 LYS A 116 CG CD CE NZ REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 ASP A 138 CG OD1 OD2 REMARK 470 LEU A 139 CG CD1 CD2 REMARK 470 GLU A 149 CG CD OE1 OE2 REMARK 470 LYS A 210 CD CE NZ REMARK 470 GLN A 211 CG CD OE1 NE2 REMARK 470 LEU A 216 CD1 CD2 REMARK 470 ASP A 230 CG OD1 OD2 REMARK 470 ASN A 280 CG OD1 ND2 REMARK 470 ILE A 299 CG2 CD1 REMARK 470 TYR A 381 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 PHE A 389 CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 448 CD CE NZ REMARK 470 HIS A 449 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 462 ND1 CD2 CE1 NE2 REMARK 470 ASN A 464 OD1 ND2 REMARK 470 HIS A 465 ND1 CD2 CE1 NE2 REMARK 470 ARG A 476 CD NE CZ NH1 NH2 REMARK 470 GLU A 480 CD OE1 OE2 REMARK 470 LYS A 490 CD CE NZ REMARK 470 GLN A 523 CD OE1 NE2 REMARK 470 TYR A 645 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR A 646 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 647 CG OD1 ND2 REMARK 470 GLU A 651 CG CD OE1 OE2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 TYR A 656 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 658 CG CD OE1 NE2 REMARK 470 HIS A 661 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 663 CG CD CE NZ REMARK 470 PHE A 667 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS A 673 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 685 CD CE NZ REMARK 470 GLN A 690 CD OE1 NE2 REMARK 470 HIS A 691 ND1 CD2 CE1 NE2 REMARK 470 TYR A 702 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 703 CD OE1 NE2 REMARK 470 ASP A 704 CG OD1 OD2 REMARK 470 ASP A 707 CG OD1 OD2 REMARK 470 ARG A 710 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 731 CD OE1 OE2 REMARK 470 GLU A 782 CG CD OE1 OE2 REMARK 470 GLU A 804 CD OE1 OE2 REMARK 470 MET A 849 CG SD CE REMARK 470 THR A 850 OG1 CG2 REMARK 470 ARG A 930 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 931 CG1 CG2 REMARK 470 ASP A1008 CG OD1 OD2 REMARK 470 LYS A1027 CG CD CE NZ REMARK 470 GLN A1066 CD OE1 NE2 REMARK 470 LYS A1098 CD CE NZ REMARK 470 LYS A1120 CG CD CE NZ REMARK 470 THR A1121 OG1 CG2 REMARK 470 ASN A1123 CG OD1 ND2 REMARK 470 GLN A1124 CG CD OE1 NE2 REMARK 470 LYS A1126 CG CD CE NZ REMARK 470 HIS A1146 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A1150 CD CE NZ REMARK 470 MET A1156 CG SD CE REMARK 470 GLU A1165 CG CD OE1 OE2 REMARK 470 GLU A1189 CD OE1 OE2 REMARK 470 GLU A1200 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 443 CA - CB - CG ANGL. DEV. = 15.8 DEGREES REMARK 500 THR A 519 C - N - CA ANGL. DEV. = 15.3 DEGREES REMARK 500 ALY A 635 O - C - N ANGL. DEV. = -11.2 DEGREES REMARK 500 ASP A 665 CB - CG - OD1 ANGL. DEV. = 7.9 DEGREES REMARK 500 LEU A1141 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 C G 11 C2 - N1 - C1' ANGL. DEV. = 8.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 3 37.81 -98.58 REMARK 500 LYS A 82 76.40 -100.16 REMARK 500 ASP A 89 -2.75 67.07 REMARK 500 ASN A 113 -11.74 83.57 REMARK 500 LYS A 118 80.55 63.54 REMARK 500 TYR A 121 -21.10 73.71 REMARK 500 ASP A 122 -6.05 60.52 REMARK 500 LYS A 134 -9.00 72.24 REMARK 500 GLU A 135 141.47 -174.00 REMARK 500 LEU A 154 -49.21 82.38 REMARK 500 LEU A 422 -3.61 66.32 REMARK 500 LEU A 451 -169.43 -79.99 REMARK 500 ASN A 464 72.74 58.33 REMARK 500 TRP A 575 -157.85 -86.30 REMARK 500 LYS A 579 57.27 -95.16 REMARK 500 PHE A 584 -4.67 70.85 REMARK 500 ASP A 591 -2.44 61.28 REMARK 500 LYS A 662 -10.34 71.18 REMARK 500 PHE A 819 72.94 59.13 REMARK 500 THR A 850 -155.25 -86.92 REMARK 500 ILE A 851 -9.06 -46.62 REMARK 500 ASN A 907 42.98 -140.35 REMARK 500 LYS A1031 -12.70 69.78 REMARK 500 GLN A1032 128.51 -170.06 REMARK 500 ASN A1125 117.21 -31.86 REMARK 500 LYS A1126 -163.51 -172.18 REMARK 500 LEU A1141 -3.07 61.94 REMARK 500 LYS A1164 -8.57 72.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 117 LYS A 118 146.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALY A 153 28.30 REMARK 500 ALY A 635 -28.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-9742 RELATED DB: EMDB REMARK 900 STRUCTURE OF A NUCLEASE FROM BACTERIA DBREF1 6IV6 A 1 1261 UNP A0A0U2B2X7_9GAMM DBREF2 6IV6 A A0A0U2B2X7 1 1261 DBREF 6IV6 G -13 45 PDB 6IV6 6IV6 -13 45 SEQRES 1 A 1261 MET LEU PHE GLN ASP PHE THR HIS LEU TYR PRO LEU SER SEQRES 2 A 1261 LYS THR VAL ARG PHE GLU LEU LYS PRO ILE GLY ALY THR SEQRES 3 A 1261 LEU GLU HIS ILE HIS ALA LYS ASN PHE LEU ASN GLN ASP SEQRES 4 A 1261 GLU THR MET ALA ASP MET TYR GLN LYS VAL LYS ALA ILE SEQRES 5 A 1261 LEU ASP ASP TYR HIS ARG ASP PHE ILE ALA ASP MET MET SEQRES 6 A 1261 GLY GLU VAL LYS LEU THR LYS LEU ALA GLU PHE TYR ASP SEQRES 7 A 1261 VAL TYR LEU LYS PHE ARG LYS ASN PRO LYS ASP ASP GLY SEQRES 8 A 1261 LEU GLN LYS GLN LEU LYS ASP LEU GLN ALA VAL LEU ARG SEQRES 9 A 1261 LYS GLU ILE VAL LYS PRO ILE GLY ASN GLY GLY LYS TYR SEQRES 10 A 1261 LYS ALA GLY TYR ASP ARG LEU PHE GLY ALA LYS LEU PHE SEQRES 11 A 1261 LYS ASP GLY LYS GLU LEU GLY ASP LEU ALA LYS PHE VAL SEQRES 12 A 1261 ILE ALA GLN GLU GLY GLU SER SER PRO ALY LEU ALA HIS SEQRES 13 A 1261 LEU ALA HIS PHE GLU LYS PHE SER THR TYR PHE THR GLY SEQRES 14 A 1261 PHE HIS ASP ASN ARG LYS ASN MET TYR SER ASP GLU ASP SEQRES 15 A 1261 LYS HIS THR ALA ILE ALA TYR ARG LEU ILE HIS GLU ASN SEQRES 16 A 1261 LEU PRO ARG PHE ILE ASP ASN LEU GLN ILE LEU ALA THR SEQRES 17 A 1261 ILE LYS GLN LYS HIS SER ALA LEU TYR ASP GLN ILE ILE SEQRES 18 A 1261 ASN GLU LEU THR ALA SER GLY LEU ASP VAL SER LEU ALA SEQRES 19 A 1261 SER HIS LEU ASP GLY TYR HIS LYS LEU LEU THR GLN GLU SEQRES 20 A 1261 GLY ILE THR ALA TYR ASN THR LEU LEU GLY GLY ILE SER SEQRES 21 A 1261 GLY GLU ALA GLY SER ARG LYS ILE GLN GLY ILE ASN GLU SEQRES 22 A 1261 LEU ILE ASN SER HIS HIS ASN GLN HIS CYS HIS LYS SER SEQRES 23 A 1261 GLU ARG ILE ALA LYS LEU ARG PRO LEU HIS LYS GLN ILE SEQRES 24 A 1261 LEU SER ASP GLY MET GLY VAL SER PHE LEU PRO SER LYS SEQRES 25 A 1261 PHE ALA ASP ASP SER GLU VAL CYS GLN ALA VAL ASN GLU SEQRES 26 A 1261 PHE TYR ARG HIS TYR ALA ASP VAL PHE ALA LYS VAL GLN SEQRES 27 A 1261 SER LEU PHE ASP GLY PHE ASP ASP TYR GLN LYS ASP GLY SEQRES 28 A 1261 ILE TYR VAL GLU TYR LYS ASN LEU ASN GLU LEU SER LYS SEQRES 29 A 1261 GLN ALA PHE GLY ASP PHE ALA LEU LEU GLY ARG VAL LEU SEQRES 30 A 1261 ASP GLY TYR TYR VAL ASP VAL VAL ASN PRO GLU PHE ASN SEQRES 31 A 1261 GLU ARG PHE ALA LYS ALA LYS THR ASP ASN ALA LYS ALA SEQRES 32 A 1261 LYS LEU THR LYS GLU LYS ASP LYS PHE ILE LYS GLY VAL SEQRES 33 A 1261 HIS SER LEU ALA SER LEU GLU GLN ALA ILE GLU HIS TYR SEQRES 34 A 1261 THR ALA ARG HIS ASP ASP GLU SER VAL GLN ALA GLY LYS SEQRES 35 A 1261 LEU GLY GLN TYR PHE LYS HIS GLY LEU ALA GLY VAL ASP SEQRES 36 A 1261 ASN PRO ILE GLN LYS ILE HIS ASN ASN HIS SER THR ILE SEQRES 37 A 1261 LYS GLY PHE LEU GLU ARG GLU ARG PRO ALA GLY GLU ARG SEQRES 38 A 1261 ALA LEU PRO LYS ILE LYS SER ASP LYS SER PRO GLU ILE SEQRES 39 A 1261 ARG GLN LEU LYS GLU LEU LEU ASP ASN ALA LEU ASN VAL SEQRES 40 A 1261 ALA HIS PHE ALA LYS LEU LEU THR THR LYS THR THR LEU SEQRES 41 A 1261 HIS ASN GLN ASP GLY ASN PHE TYR GLY GLU PHE GLY ALA SEQRES 42 A 1261 LEU TYR ASP GLU LEU ALA LYS ILE ALA THR LEU TYR ASN SEQRES 43 A 1261 LYS VAL ARG ASP TYR LEU SER GLN LYS PRO PHE SER THR SEQRES 44 A 1261 GLU LYS TYR LYS LEU ASN PHE GLY ASN PRO THR LEU LEU SEQRES 45 A 1261 ASN GLY TRP ASP LEU ASN LYS GLU LYS ASP ASN PHE GLY SEQRES 46 A 1261 VAL ILE LEU GLN LYS ASP GLY CYS TYR TYR LEU ALA LEU SEQRES 47 A 1261 LEU ASP LYS ALA HIS LYS LYS VAL PHE ASP ASN ALA PRO SEQRES 48 A 1261 ASN THR GLY LYS SER VAL TYR GLN LYS MET ILE TYR LYS SEQRES 49 A 1261 LEU LEU PRO GLY PRO ASN LYS MET LEU PRO ALY VAL PHE SEQRES 50 A 1261 PHE ALA LYS SER ASN LEU ASP TYR TYR ASN PRO SER ALA SEQRES 51 A 1261 GLU LEU LEU ASP LYS TYR ALA GLN GLY THR HIS LYS LYS SEQRES 52 A 1261 GLY ASP ASN PHE ASN LEU LYS ASP CYS HIS ALA LEU ILE SEQRES 53 A 1261 ASP PHE PHE LYS ALA GLY ILE ASN LYS HIS PRO GLU TRP SEQRES 54 A 1261 GLN HIS PHE GLY PHE LYS PHE SER PRO THR SER SER TYR SEQRES 55 A 1261 GLN ASP LEU SER ASP PHE TYR ARG GLU VAL GLU PRO GLN SEQRES 56 A 1261 GLY TYR GLN VAL LYS PHE VAL ASP ILE ASN ALA ASP TYR SEQRES 57 A 1261 ILE ASN GLU LEU VAL GLU GLN GLY GLN LEU TYR LEU PHE SEQRES 58 A 1261 GLN ILE TYR ASN LYS ASP PHE SER PRO LYS ALA HIS GLY SEQRES 59 A 1261 LYS PRO ASN LEU HIS THR LEU TYR PHE LYS ALA LEU PHE SEQRES 60 A 1261 SER GLU ASP ASN LEU VAL ASN PRO ILE TYR LYS LEU ASN SEQRES 61 A 1261 GLY GLU ALA GLU ILE PHE TYR ARG LYS ALA SER LEU ASP SEQRES 62 A 1261 MET ASN GLU THR THR ILE HIS ARG ALA GLY GLU VAL LEU SEQRES 63 A 1261 GLU ASN LYS ASN PRO ASP ASN PRO LYS ALY ARG GLN PHE SEQRES 64 A 1261 VAL TYR ASP ILE ILE LYS ASP LYS ARG TYR THR GLN ASP SEQRES 65 A 1261 LYS PHE MET LEU HIS VAL PRO ILE THR MET ASN PHE GLY SEQRES 66 A 1261 VAL GLN GLY MET THR ILE LYS GLU PHE ASN LYS LYS VAL SEQRES 67 A 1261 ASN GLN SER ILE GLN GLN TYR ASP GLU VAL ASN VAL ILE SEQRES 68 A 1261 GLY ILE ASP ARG GLY GLU ARG HIS LEU LEU TYR LEU THR SEQRES 69 A 1261 VAL ILE ASN SER LYS GLY GLU ILE LEU GLU GLN ARG SER SEQRES 70 A 1261 LEU ASN ASP ILE THR THR ALA SER ALA ASN GLY THR GLN SEQRES 71 A 1261 MET THR THR PRO TYR HIS LYS ILE LEU ASP LYS ARG GLU SEQRES 72 A 1261 ILE GLU ARG LEU ASN ALA ARG VAL GLY TRP GLY GLU ILE SEQRES 73 A 1261 GLU THR ILE LYS GLU LEU LYS SER GLY TYR LEU SER HIS SEQRES 74 A 1261 VAL VAL HIS GLN ILE SER GLN LEU MET LEU LYS TYR ASN SEQRES 75 A 1261 ALA ILE VAL VAL LEU GLU ASP LEU ASN PHE GLY PHE LYS SEQRES 76 A 1261 ARG GLY CYS PHE LYS VAL GLU LYS GLN ILE TYR GLN ASN SEQRES 77 A 1261 PHE GLU ASN ALA LEU ILE LYS LYS LEU ASN HIS LEU VAL SEQRES 78 A 1261 LEU LYS ASP LYS ALA ASP ASP GLU ILE GLY SER TYR LYS SEQRES 79 A 1261 ASN ALA LEU GLN LEU THR ASN ASN PHE THR ASP LEU LYS SEQRES 80 A 1261 SER ILE GLY LYS GLN THR GLY PHE LEU PHE TYR VAL PRO SEQRES 81 A 1261 ALA TRP ASN THR SER LYS ILE ASP PRO GLU THR GLY PHE SEQRES 82 A 1261 VAL ASP LEU LEU LYS PRO ARG TYR GLU ASN ILE ALA GLN SEQRES 83 A 1261 SER GLN ALA PHE PHE GLY LYS PHE ASP LYS ILE CYS TYR SEQRES 84 A 1261 ASN ALA ASP ARG GLY TYR PHE GLU PHE HIS ILE ASP TYR SEQRES 85 A 1261 ALA LYS PHE ASN ASP LYS ALA LYS ASN SER ARG GLN ILE SEQRES 86 A 1261 TRP LYS ILE CYS SER HIS GLY ASP LYS ARG TYR VAL TYR SEQRES 87 A 1261 ASP LYS THR ALA ASN GLN ASN LYS GLY ALA THR ILE GLY SEQRES 88 A 1261 VAL ASN VAL ASN ASP GLU LEU LYS SER LEU PHE THR ARG SEQRES 89 A 1261 TYR HIS ILE ASN ASP LYS GLN PRO ASN LEU VAL MET ASP SEQRES 90 A 1261 ILE CYS GLN ASN ASN ASP LYS GLU PHE HIS LYS SER LEU SEQRES 91 A 1261 MET TYR LEU LEU LYS THR LEU LEU ALA LEU ARG TYR SER SEQRES 92 A 1261 ASN ALA SER SER ASP GLU ASP PHE ILE LEU SER PRO VAL SEQRES 93 A 1261 ALA ASN ASP GLU GLY VAL PHE PHE ASN SER ALA LEU ALA SEQRES 94 A 1261 ASP ASP THR GLN PRO GLN ASN ALA ASP ALA ASN GLY ALA SEQRES 95 A 1261 TYR HIS ILE ALA LEU LYS GLY LEU TRP LEU LEU ASN GLU SEQRES 96 A 1261 LEU LYS ASN SER ASP ASP LEU ASN LYS VAL LYS LEU ALA SEQRES 97 A 1261 ILE ASP ASN GLN THR TRP LEU ASN PHE ALA GLN ASN ARG SEQRES 1 G 59 G U C U A A C G A C C U U SEQRES 2 G 59 U U A A A U U U C U A C U SEQRES 3 G 59 G U U U G U A G A U C U G SEQRES 4 G 59 A U G G U C C A U G U C U SEQRES 5 G 59 G U U A C U C MODRES 6IV6 ALY A 25 LYS MODIFIED RESIDUE MODRES 6IV6 ALY A 153 LYS MODIFIED RESIDUE MODRES 6IV6 ALY A 635 LYS MODIFIED RESIDUE MODRES 6IV6 ALY A 816 LYS MODIFIED RESIDUE HET ALY A 25 12 HET ALY A 153 12 HET ALY A 635 12 HET ALY A 816 12 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 1 ALY 4(C8 H16 N2 O3) HELIX 1 AA1 THR A 26 ASN A 34 1 9 HELIX 2 AA2 ASN A 34 MET A 65 1 32 HELIX 3 AA3 LYS A 72 LEU A 81 1 10 HELIX 4 AA4 LEU A 92 LYS A 109 1 18 HELIX 5 AA5 LYS A 141 GLN A 146 1 6 HELIX 6 AA6 PHE A 163 THR A 168 5 6 HELIX 7 AA7 GLY A 169 LYS A 175 1 7 HELIX 8 AA8 ALA A 186 HIS A 193 1 8 HELIX 9 AA9 GLU A 194 ALA A 207 1 14 HELIX 10 AB1 TYR A 217 THR A 225 1 9 HELIX 11 AB2 ASP A 230 ALA A 234 5 5 HELIX 12 AB3 TYR A 240 LEU A 244 5 5 HELIX 13 AB4 THR A 245 GLY A 258 1 14 HELIX 14 AB5 GLY A 270 HIS A 279 1 10 HELIX 15 AB6 ASP A 315 PHE A 326 1 12 HELIX 16 AB7 ALA A 335 GLY A 343 1 9 HELIX 17 AB8 GLU A 355 LYS A 357 5 3 HELIX 18 AB9 ASN A 358 ALA A 366 1 9 HELIX 19 AC1 ALA A 371 TYR A 380 1 10 HELIX 20 AC2 TYR A 381 VAL A 385 5 5 HELIX 21 AC3 ALA A 425 ARG A 432 1 8 HELIX 22 AC4 ASP A 455 LYS A 460 1 6 HELIX 23 AC5 ASN A 464 LYS A 469 1 6 HELIX 24 AC6 ILE A 494 LEU A 501 1 8 HELIX 25 AC7 LEU A 501 ALA A 511 1 11 HELIX 26 AC8 ASP A 524 ALA A 539 1 16 HELIX 27 AC9 LYS A 540 SER A 553 1 14 HELIX 28 AD1 LYS A 579 PHE A 584 1 6 HELIX 29 AD2 GLY A 628 LEU A 633 1 6 HELIX 30 AD3 PRO A 648 ALA A 657 1 10 HELIX 31 AD4 GLY A 659 LYS A 663 5 5 HELIX 32 AD5 LEU A 669 HIS A 686 1 18 HELIX 33 AD6 ASP A 704 GLY A 716 1 13 HELIX 34 AD7 ASN A 725 GLU A 734 1 10 HELIX 35 AD8 ASN A 745 SER A 749 5 5 HELIX 36 AD9 ASN A 757 LYS A 764 1 8 HELIX 37 AE1 SER A 768 LEU A 772 5 5 HELIX 38 AE2 ASP A 826 GLN A 831 1 6 HELIX 39 AE3 THR A 850 PHE A 854 5 5 HELIX 40 AE4 ASN A 855 TYR A 865 1 11 HELIX 41 AE5 TYR A 915 ARG A 926 1 12 HELIX 42 AE6 GLY A 934 ASN A 962 1 29 HELIX 43 AE7 GLU A 982 HIS A 999 1 18 HELIX 44 AE8 ASN A 1063 GLY A 1072 1 10 HELIX 45 AE9 ASN A 1133 LEU A 1138 1 6 HELIX 46 AF1 LEU A 1154 CYS A 1159 1 6 HELIX 47 AF2 GLU A 1165 ALA A 1179 1 15 HELIX 48 AF3 ASN A 1216 ASN A 1238 1 23 HELIX 49 AF4 ASP A 1250 ASN A 1260 1 11 SHEET 1 AA1 8 PHE A 721 ILE A 724 0 SHEET 2 AA1 8 TYR A 618 MET A 621 -1 N TYR A 618 O ILE A 724 SHEET 3 AA1 8 GLY A 585 GLN A 589 -1 N GLN A 589 O GLN A 619 SHEET 4 AA1 8 TYR A 594 LEU A 598 -1 O TYR A 595 N LEU A 588 SHEET 5 AA1 8 TYR A 739 TYR A 744 -1 O PHE A 741 N LEU A 596 SHEET 6 AA1 8 LEU A 12 PRO A 22 -1 N GLU A 19 O TYR A 744 SHEET 7 AA1 8 LEU A 836 MET A 842 -1 O VAL A 838 N VAL A 16 SHEET 8 AA1 8 TYR A 777 LEU A 779 -1 N LYS A 778 O THR A 841 SHEET 1 AA2 3 LYS A 561 LEU A 564 0 SHEET 2 AA2 3 ILE A 785 ARG A 788 -1 O ILE A 785 N LEU A 564 SHEET 3 AA2 3 LYS A 833 PHE A 834 -1 O LYS A 833 N ARG A 788 SHEET 1 AA3 2 LYS A 624 LEU A 625 0 SHEET 2 AA3 2 TYR A 717 GLN A 718 -1 O GLN A 718 N LYS A 624 SHEET 1 AA4 6 ILE A 892 SER A 897 0 SHEET 2 AA4 6 LEU A 881 ILE A 886 -1 N VAL A 885 O LEU A 893 SHEET 3 AA4 6 ASN A 869 ARG A 875 -1 N VAL A 870 O ILE A 886 SHEET 4 AA4 6 ALA A 963 GLU A 968 1 O ILE A 964 N ILE A 871 SHEET 5 AA4 6 LEU A1036 VAL A1039 1 O PHE A1037 N LEU A 967 SHEET 6 AA4 6 GLN A1032 THR A1033 -1 N THR A1033 O LEU A1036 SHEET 1 AA5 2 ASP A 900 SER A 905 0 SHEET 2 AA5 2 GLN A 910 PRO A 914 -1 O THR A 913 N ILE A 901 SHEET 1 AA6 3 ILE A1077 TYR A1079 0 SHEET 2 AA6 3 PHE A1086 ASP A1091 -1 O GLU A1087 N CYS A1078 SHEET 3 AA6 3 ILE A1105 CYS A1109 -1 O ILE A1108 N PHE A1088 SHEET 1 AA7 2 ARG A1181 SER A1183 0 SHEET 2 AA7 2 ASP A1190 ILE A1192 -1 O PHE A1191 N TYR A1182 LINK C GLY A 24 N ALY A 25 1555 1555 1.33 LINK C ALY A 25 N THR A 26 1555 1555 1.33 LINK C PRO A 152 N ALY A 153 1555 1555 1.33 LINK C ALY A 153 N LEU A 154 1555 1555 1.33 LINK C PRO A 634 N ALY A 635 1555 1555 1.33 LINK C ALY A 635 N VAL A 636 1555 1555 1.33 LINK C LYS A 815 N ALY A 816 1555 1555 1.33 LINK C ALY A 816 N ARG A 817 1555 1555 1.33 CISPEP 1 LEU A 81 LYS A 82 0 -3.60 CISPEP 2 THR A 518 THR A 519 0 6.03 CISPEP 3 PRO A 1152 ASN A 1153 0 -8.72 CISPEP 4 LEU A 1208 ALA A 1209 0 3.74 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000